Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1726114 | 0.87 | TSHR (0.44) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| Bromide SCHEMBL3630569 | 0.80 | TSHR (0.56) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL8177305 | 0.78 | TSHR (0.46) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| Bromide SCHEMBL3623040 | 0.78 | TSHR (0.51) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL1477898 | 0.77 | TSHR (0.50) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL14882 | 0.77 | TSHR (0.63) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL27971941 | 0.75 | TSHR (0.49) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL29966916 | 0.75 | TSHR (0.32) | TSHRHPGDALDH1A1CYP3A4 | |
| SCHEMBL316981 | 0.75 | TSHR (0.61) | TSHRHPGDALDH1A1CYP3A4TP53 | |
| SCHEMBL2457988 | 0.75 | TSHR (0.61) | TSHRHPGDALDH1A1CYP3A4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1675880-B1 | METHOD FOR PARTIAL OR TOTAL OXIDATION OF ONE OR SEVERAL THIOCARBONYLTHIO ENDS OF A POLYMER OBTAINED BY RADICAL POLYMERISATION CONTROLLED BY REVERSIBLE ADDITION-CLEAVAGE | RHODIA CHIMIE SA (FR) | 2019-03-13 | — | — | EP | claimed |
| US-7728088-B2 | Synthesis of statistical microgels by means of controlled radical polymerisation | RHODIA OPERATIONS (FR) | 2010-06-01 | — | — | US | claimed |
| US-7473740-B2 | Oxidizing one or more thiocarbonylthio ends of a polymer resulting from a radical polymerization controlled by reversible addition-fragmentation using thiocarbonylthio by reacting with ozone | RHODIA CHIMIE (FR) | 2009-01-06 | — | — | US | claimed |
| US-20070027266-A1 | Oxidizing one or more thiocarbonylthio ends of a polymer resulting from a radical polymerization controlled by reversible addition-fragmentation using thiocarbonylthio by reacting with ozone | SPECIALTY OPERATIONS FRANCE (FR) | 2007-02-01 | — | — | US | claimed |
| US-20060106178-A1 | Synthesis of statistical microgels by means of controlled radical polymerisation | RHODIA CHIMIE (FR) | 2006-05-18 | — | — | US | claimed |
| EP-1278809-B1 | SILICONE/ADHESIVE COMPLEX WHEREOF THE INTERFACE HAS A RELEASE FORCE CAPABLE OF BEING MODULATED BY ELECTRON BEAM IRRADIATION | RHODIA CHIMIE SA (FR) | 2005-11-09 | — | — | EP | claimed |
| EP-1242552-B1 | CATION-CURABLE SILICONE /ADHESIVE COMPLEX WHEREOF THE INTERFACE HAS RELEASE FORCE CAPABLE OF BEING MODULATED | RHODIA CHIMIE SA (FR) | 2005-02-09 | — | — | EP | claimed |
| EP-1123360-B1 | COATING COMPOSITIONS CONTAINING FUNCTIONALISED SILICONES | RHODIA CHIMIE SA (FR) | 2004-12-15 | — | — | EP | claimed |
| EP-1040142-B1 | USE OF AN AQUEOUS PRESSURE SENSITIVE ADHESIVE (PSA) EMULSION, WITH HIGH SHEARING RESISTANCE | RHODIA CHIMIE SA (FR) | 2004-06-23 | — | — | EP | claimed |
| US-20030186013-A1 | Silicone/adhesive complex whereof the interface has a release force capable of being modulated by electron beam irradiation | RHODIA CHIMIE (FR) | 2003-10-02 | — | — | US | claimed |
| US-6590026-B1 | Epoxyfunctionalized polysiloxane emulsion, latex, and mineral filler; paints, coatings | RHODIA CHIMIE (FR) | 2003-07-08 | — | — | US | claimed |
| US-11834429-B2 | Monoethylenically unsaturated monomers and uses thereof | BOSTIK SA (FR) | 2023-12-05 | — | — | US | disclosed |
| US-20210179576-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | UNIVERSITE DE RENNES (FR) | 2021-06-17 | — | — | US | disclosed |
| EP-1490411-B1 | METHOD FOR CONTROLLING THE STABILITY OF EMULSIONS AND STABILIZED EMULSIONS | RHODIA CHIMIE SA (FR) | 2009-01-21 | — | — | EP | disclosed |
| US-7473740-B2 | Oxidizing one or more thiocarbonylthio ends of a polymer resulting from a radical polymerization controlled by reversible addition-fragmentation using thiocarbonylthio by reacting with ozone | RHODIA CHIMIE (FR) | 2009-01-06 | — | — | US | disclosed |
| CN-1216052-A | Composite particles including organic polymer and oxide and/or hydroxide | RHODIA CHIMIE SA (FR) | 1999-05-05 | — | — | CN | disclosed |
| US-5756210-A | USE AS FILLERS OR ADDITIVES IN PLASTICS AND ELASTOMERS | RHONE-POULENC CHIMIE (FR) | 1998-05-26 | — | — | US | disclosed |
| US-5721026-A | CATIONIC OR NONIONIC SURFACTANT STABILIZERS; CROSSLINKING AGENT; NONSILICEOUS FILLER MATERIAL | RHONE-POULENC CHIMIE (FR) | 1998-02-24 | — | — | US | disclosed |
| US-5395903-A | Conjugated diene chain-transfer agents for polymerization of olefinically unsaturated (co)monomers | RHONE-POULENC CHIMIE (FR) | 1995-03-07 | — | — | US | disclosed |
| US-5360851-A | Seals and molding materials | RHONE-POULENC CHIMIE (FR) | 1994-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834429-B2 | Monoethylenically unsaturated monomers and uses thereof | MEP1A, MEP1B, ALOX5 | TSHR 4885/4885HPGD 278/4885ALDH1A1 581/4885 |
| US-20210179576-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | MEP1A, MEP1B, ALOX5 | TSHR 4885/4885HPGD 278/4885ALDH1A1 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.